Intensive Care Medicine

, Volume 36, Issue 1, pp 66–74 | Cite as

Usefulness of a clinical diagnosis of ICU-acquired paresis to predict outcome in patients with SIRS and acute respiratory failure

  • Anna-Giulia Brunello
  • Matthias Haenggi
  • Oliver Wigger
  • Francesca Porta
  • Jukka Takala
  • Stephan M. JakobEmail author



Neuromuscular abnormalities are common in ICU patients. We aimed to assess the incidence of clinically diagnosed ICU-acquired paresis (ICUAP) and its impact on outcome.


Forty-two patients with systemic inflammatory response syndrome on mechanical ventilation for ≥48 h were prospectively studied. Diagnosis of ICUAP was defined as symmetric limb muscle weakness in at least two muscle groups at ICU discharge without other explanation. The threshold Medical Research Council (MRC) Score was set at 35 (of 50) points. Activities in daily living were scored using the Barthel Index 28 and 180 days after ICU discharge.


Three patients died before sedation was stopped. ICUAP was diagnosed in 13 of the 39 patients (33%). Multivariate regression analysis yielded five ICUAP-predicting variables (P < 0.05): SAPS II at ICU admission, treatment with steroids, muscle relaxants or norepinephrine, and days with sepsis. Patients with ICUAP had lower admission SAPS II scores [37 ± 13 vs. 49 ± 15 (P = 0.018)], lower Barthel Index at 28 days and lower survival at 180 days after ICU discharge (38 vs. 77%, P = 0.033) than patients without ICUAP. Daily TISS-28 scores were similar but cumulative TISS-28 scores were higher in patients with ICUAP (664 ± 275) than in patients without ICUAP (417 ± 236; P = 0.008). The only independent risk factor for death before day 180 was the presence of ICUAP.


A clinical diagnosis of ICUAP was frequently established in this patient group. Despite lower SAPS II scores, these patients needed more resources and had high mortality and prolonged recovery periods after ICU discharge.


ICU-acquired paresis (ICUAP) Systemic inflammatory response syndrome (SIRS) Multiorgan failure (MOF) Mechanical ventilation Prolonged weaning Barthel Index 

Supplementary material

134_2009_1645_MOESM1_ESM.doc (234 kb)
Supplementary material 1 (DOC 234 kb)


  1. 1.
    Bolton CF, Gilbert JJ, Hahn AF, Sibbald WJ (1984) Polyneuropathy in critically ill patients. J Neurol Neurosurg Psychiatry 47:1223–1231CrossRefPubMedGoogle Scholar
  2. 2.
    Bolton CF (2005) Neuromuscular manifestations of critical illness. Muscle Nerve 32:140–163CrossRefPubMedGoogle Scholar
  3. 3.
    Latronico N, Bertolini G, Guarneri B, Botteri M, Peli E, Andreoletti S, Bera P, Luciani D, Nardella A, Vittorielli E, Simini B, Candiani A (2007) Simplified electrophysiological evaluation of peripheral nerves in critically ill patients: the Italian multi-centre CRIMYNE study. Crit Care 11:R11CrossRefPubMedGoogle Scholar
  4. 4.
    Bolton CF, Laverty DA, Brown JD, Witt NJ, Hahn AF, Sibbald WJ (1986) Critically ill polyneuropathy: electrophysiological studies and differentiation from Guillain–Barre syndrome. J Neurol Neurosurg Psychiatry 49:563–573CrossRefPubMedGoogle Scholar
  5. 5.
    Lopez Messa JB, Garcia A (1990) Acute polyneuropathy in critically ill patients. Intensive Care Med 16:159–162CrossRefPubMedGoogle Scholar
  6. 6.
    Hund EF, Fogel W, Krieger D, DeGeorgia M, Hacke W (1996) Critical illness polyneuropathy: clinical findings and outcomes of a frequent cause of neuromuscular weaning failure. Crit Care Med 24:1328–1333CrossRefPubMedGoogle Scholar
  7. 7.
    Coakley JH, Nagendran K, Yarwood GD, Honavar M, Hinds CJ (1998) Patterns of neurophysiological abnormality in prolonged critical illness. Intensive Care Med 24:801–807CrossRefPubMedGoogle Scholar
  8. 8.
    Berek K, Margreiter J, Willeit J, Berek A, Schmutzhard E, Mutz NJ (1996) Polyneuropathies in critically ill patients: a prospective evaluation. Intensive Care Med 22:849–855CrossRefPubMedGoogle Scholar
  9. 9.
    Maher J, Rutledge F, Remtulla H, Parkes A, Bernardi L, Bolton CF (1995) Neuromuscular disorders associated with failure to wean from the ventilator. Intensive Care Med 21:737–743CrossRefPubMedGoogle Scholar
  10. 10.
    Zochodne DW, Bolton CF, Wells GA, Gilbert JJ, Hahn AF, Brown JD, Sibbald WA (1987) Critical illness polyneuropathy. A complication of sepsis and multiple organ failure. Brain 110(Pt 4):819–841CrossRefPubMedGoogle Scholar
  11. 11.
    Latronico N (2003) Neuromuscular alterations in the critically ill patient: critical illness myopathy, critical illness neuropathy, or both? Intensive Care Med 29:1411–1413CrossRefPubMedGoogle Scholar
  12. 12.
    Latronico N, Recupero D, Candiani A, Guarneri B, De Maria G, Antonini L, Fenzi F, Tomelleri G, Tonin P, Rizzuto N (1996) Critical illness myopathy and neuropathy. Lancet 347:1579–1582CrossRefPubMedGoogle Scholar
  13. 13.
    Bednarik J, Lukas Z, Vondracek P (2003) Critical illness polyneuromyopathy: the electrophysiological components of a complex entity. Intensive Care Med 29:1505–1514CrossRefPubMedGoogle Scholar
  14. 14.
    De Jonghe B, Sharshar T, Lefaucheur JP, Authier FJ, Durand-Zaleski I, Boussarsar M, Cerf C, Renaud E, Mesrati F, Carlet J, Raphael JC, Outin H, Bastuji-Garin S (2002) Paresis acquired in the intensive care unit: a prospective multicenter study. JAMA 288:2859–2867CrossRefPubMedGoogle Scholar
  15. 15.
    Ali NA, O’Brien JM Jr, Hoffmann SP, Phillips G, Garland A, Finley JC, Almoosa K, Hejal R, Wolf KM, Lemeshow S, Connors AF Jr, Marsh CB (2008) Acquired weakness, handgrip strength, and mortality in critically ill patients. Am J Respir Crit Care Med 178:261–268CrossRefPubMedGoogle Scholar
  16. 16.
    Stevens RD, Dowdy DW, Michaels RK, Mendez-Tellez PA, Pronovost PJ, Needham DM (2007) Neuromuscular dysfunction acquired in critical illness: a systematic review. Intensive Care Med 33:1876–1891CrossRefPubMedGoogle Scholar
  17. 17.
    Brunello A, Wigger O, Porta F, Ganter C, Haenggi M, Takala J, Jakob SM (2007) Long-term effects of a clinical diagnosis of critical illness polyneuro-myopathy in patients with systemic inflammation. Intensive Care Med 33:S23Google Scholar
  18. 18.
    Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 101:1644–1655CrossRefPubMedGoogle Scholar
  19. 19.
    Le Gall JR, Lemeshow S, Saulnier F (1993) A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 270:2957–2963CrossRefPubMedGoogle Scholar
  20. 20.
    Vincent JL, Moreno R, Takala J, Willatts S, de Mendonca A, Bruining H, Reinhart CK, Suter PM, Thijs LG (1996) The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. Intensive Care Med 22:707–710CrossRefPubMedGoogle Scholar
  21. 21.
    Takala J, Dellinger RP, Koskinen K, St AA, Read M, Levy M, Jakob SM, Mello PV, Friolet R, Ruokonen E (2008) Development and simultaneous application of multiple care protocols in critical care: a multicenter feasibility study. Intensive Care Med 34:1401–1410CrossRefPubMedGoogle Scholar
  22. 22.
    Sessler CN, Gosnell MS, Grap MJ, Brophy GM, O’Neal PV, Keane KA, Tesoro EP, Elswick RK (2002) The Richmond Agitation-Sedation Scale: validity and reliability in adult intensive care unit patients. Am J Respir Crit Care Med 166:1338–1344CrossRefPubMedGoogle Scholar
  23. 23.
    Jennett B, Teasdale G, Braakman R, Minderhoud J, Knill-Jones R (1976) Predicting outcome in individual patients after severe head injury. Lancet 1:1031–1034CrossRefPubMedGoogle Scholar
  24. 24.
    Kleyweg RP, van der Meche FG, Schmitz PI (1991) Interobserver agreement in the assessment of muscle strength and functional abilities in Guillain–Barre syndrome. Muscle Nerve 14:1103–1109CrossRefPubMedGoogle Scholar
  25. 25.
    Mahoney FI, Barthel DW (1965) Functional evaluation: the Barthel Index. Md State Med J 14:61–65PubMedGoogle Scholar
  26. 26.
    Stricker K, Rothen HU, Takala J (2003) Resource use in the ICU: short- vs. long-term patients. Acta Anaesthesiol Scand 47:508–515CrossRefPubMedGoogle Scholar
  27. 27.
    Zifko UA (2000) Long-term outcome of critical illness polyneuropathy. Muscle Nerve Suppl 9:S49–S52CrossRefPubMedGoogle Scholar
  28. 28.
    de Letter MA, Schmitz PI, Visser LH, Verheul FA, Schellens RL, Op de Coul DA, van der Meche FG (2001) Risk factors for the development of polyneuropathy and myopathy in critically ill patients. Crit Care Med 29:2281–2286CrossRefPubMedGoogle Scholar
  29. 29.
    Kane SL, Dasta JF (2002) Clinical outcomes of critical illness polyneuropathy. Pharmacotherapy 22:373–379CrossRefPubMedGoogle Scholar
  30. 30.
    van Mook WN, Hulsewe-Evers RP (2002) Critical illness polyneuropathy. Curr Opin Crit Care 8:302–310CrossRefPubMedGoogle Scholar
  31. 31.
    Garnacho-Montero J, Madrazo-Osuna J, Garcia-Garmendia JL, Ortiz-Leyba C, Jimenez-Jimenez FJ, Barrero-Almodovar A, Garnacho-Montero MC, Moyano-Del-Estad MR (2001) Critical illness polyneuropathy: risk factors and clinical consequences. A cohort study in septic patients. Intensive Care Med 27:1288–1296CrossRefPubMedGoogle Scholar
  32. 32.
    Leijten FS, Harinck-de Weerd JE, Poortvliet DC, De Weerd AW (1995) The role of polyneuropathy in motor convalescence after prolonged mechanical ventilation. JAMA 274:1221–1225CrossRefPubMedGoogle Scholar
  33. 33.
    Tennila A, Salmi T, Pettila V, Roine RO, Varpula T, Takkunen O (2000) Early signs of critical illness polyneuropathy in ICU patients with systemic inflammatory response syndrome or sepsis. Intensive Care Med 26:1360–1363CrossRefPubMedGoogle Scholar
  34. 34.
    Morris C, Trinder JT (2002) Electrophysiology adds little to clinical signs in critical illness polyneuropathy and myopathy. Crit Care Med 30:2612CrossRefPubMedGoogle Scholar
  35. 35.
    Guarneri B, Bertolini G, Latronico N (2008) Long-term outcome in patients with critical illness myopathy or neuropathy: the Italian multicentre CRIMYNE study. J Neurol Neurosurg Psychiatry 79:838–841CrossRefPubMedGoogle Scholar
  36. 36.
    Suistomaa M, Niskanen M, Kari A, Hynynen M, Takala J (2002) Customized prediction models based on APACHE II and SAPS II scores in patients with prolonged length of stay in the ICU. Intensive Care Med 28:479–485CrossRefPubMedGoogle Scholar
  37. 37.
    De Jonghe B, Bastuji-Garin S, Durand MC, Malissin I, Rodrigues P, Cerf C, Outin H, Sharshar T (2007) Respiratory weakness is associated with limb weakness and delayed weaning in critical illness. Crit Care Med 35:2007–2015CrossRefPubMedGoogle Scholar
  38. 38.
    De Jonghe B, Bastuji-Garin S, Sharshar T, Outin H, Brochard L (2004) Does ICU-acquired paresis lengthen weaning from mechanical ventilation? Intensive Care Med 30:1117–1121CrossRefPubMedGoogle Scholar
  39. 39.
    Hermans G, Wilmer A, Meersseman W, Milants I, Wouters PJ, Bobbaers H, Bruyninckx F, Van den Berghe G (2007) Impact of intensive insulin therapy on neuromuscular complications and ventilator dependency in the medical intensive care unit. Am J Respir Crit Care Med 175:480–489CrossRefPubMedGoogle Scholar
  40. 40.
    Bednarik J, Vondracek P, Dusek L, Moravcova E, Cundrle I (2005) Risk factors for critical illness polyneuromyopathy. J Neurol 252:343–351CrossRefPubMedGoogle Scholar
  41. 41.
    Zifko UA, Zipko HT, Bolton CF (1998) Clinical and electrophysiological findings in critical illness polyneuropathy. J Neurol Sci 159:186–193CrossRefPubMedGoogle Scholar

Copyright information

© Copyright jointly hold by Springer and ESICM 2009

Authors and Affiliations

  • Anna-Giulia Brunello
    • 1
  • Matthias Haenggi
    • 1
  • Oliver Wigger
    • 1
  • Francesca Porta
    • 1
  • Jukka Takala
    • 1
  • Stephan M. Jakob
    • 1
    Email author
  1. 1.Department of Intensive Care Medicine, Inselspital, Bern University HospitalUniversity of BernBernSwitzerland

Personalised recommendations